-+ 0.00%
-+ 0.00%
-+ 0.00%

Helus Pharma Appoints Michael Halstead as Chief Executive Officer

Barchart·08/03/2026 06:40:00
Listen to the news

Former President of Intra-Cellular Therapies, Inc. was instrumental in building and scaling the company, which was subsequently acquired by Johnson & Johnson

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.